Liposome-based approaches to overcome anticancer drug resistance.
about
Therapy with sodium stibogluconate in stearylamine-bearing liposomes confers cure against SSG-resistant Leishmania donovani in BALB/c micePlasmin-loaded echogenic liposomes for ultrasound-mediated thrombolysis.A novel assay for monitoring internalization of nanocarrier coupled antibodies.The use of functional epirubicin liposomes to induce programmed death in refractory breast cancerCell-penetrating, guanidinium-rich molecular transporters for overcoming efflux-mediated multidrug resistance.Dual-functional c(RGDyK)-decorated Pluronic micelles designed for antiangiogenesis and the treatment of drug-resistant tumor.Liposomal anticancer therapy: pharmacokinetic and clinical aspects.Cyclic RGD peptide-modified liposomal drug delivery system: enhanced cellular uptake in vitro and improved pharmacokinetics in ratsEnhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell lines.Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomesOvercoming multidrug resistance of small-molecule therapeutics through conjugation with releasable octaarginine transporters.A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of CardiologyNanovehicular intracellular delivery systems.Development of inhibitors of ATP-binding cassette drug transporters: present status and challenges.Nanomicellar paclitaxel increases cytotoxicity of multidrug resistant breast cancer cellsImaging characteristics of zinc sulfide shell, cadmium telluride core quantum dots.Advances of cancer therapy by nanotechnology.Real-time MR imaging of adeno-associated viral vector delivery to the primate brain.In vivo evaluation of doxorubicin-loaded polymeric micelles targeting folate receptors and early endosomal pH in drug-resistant ovarian cancerLigand-based targeted therapy for cancer tissue.Doxorubicin in TAT peptide-modified multifunctional immunoliposomes demonstrates increased activity against both drug-sensitive and drug-resistant ovarian cancer models.Phototriggerable liposomes: current research and future perspectives.Drug delivery strategies for therapy of visceral leishmaniasis.Drug conjugates such as Antibody Drug Conjugates (ADCs), immunotoxins and immunoliposomes challenge daily clinical practice.Liposomes, a promising strategy for clinical application of platinum derivatives.Liposomal chemotherapeutics.Versatile carboxymethyl chitin and chitosan nanomaterials: a review.pH-sensitive, polymer modified, plasma stable niosomes: promising carriers for anti-cancer drugs.Prussian Blue Derived Nanoporous Iron Oxides as Anticancer Drug Carriers for Magnetic-Guided Chemotherapy.Strategies for improving drug delivery: nanocarriers and microenvironmental priming.In vitro and in vivo investigation of a novel two-phase delivery system of 2-methoxyestradiol liposomes hydrogel.Riboflavin-targeted polymer conjugates for breast tumor delivery.Immunoliposomal delivery of doxorubicin can overcome multidrug resistance mechanisms in EGFR-overexpressing tumor cells.Enhanced in vitro cellular uptake of P-gp substrate by poloxamer-modified liposomes (PMLs) in MDR cancer cells.Hyaluronic acid-paclitaxel: effects of intraperitoneal administration against CD44(+) human ovarian cancer xenografts.Reduction of doxorubicin resistance in P-glycoprotein overexpressing cells by hybrid cell-penetrating and drug-binding peptide.Liposome composition is important for retention of liposomal rhodamine in P-glycoprotein-overexpressing cancer cells.Doxorubicin-loaded polymeric micelle overcomes multidrug resistance of cancer by double-targeting folate receptor and early endosomal pH.Self-assembled polyethylenimine-graft-poly(epsilon-caprolactone) micelles as potential dual carriers of genes and anticancer drugs.EGFR-targeted immunoliposomes derived from the monoclonal antibody EMD72000 mediate specific and efficient drug delivery to a variety of colorectal cancer cells.
P2860
Q28477398-BE9C182F-B1D1-43D2-AE7C-C59A846FDCC2Q30392562-FA9755F4-D7DE-42DA-948B-2974E30380D6Q33259109-7DB3EBB1-BA3A-4205-B7BD-B7F57807464FQ33766573-2D11B6F9-F686-4216-8628-57948DEB4FEAQ34011165-38D5BAE4-35FA-495E-8E9F-81F6E179F6B9Q35918831-3A944901-0CD9-42F3-A584-1249D72AB46AQ36028708-06B66649-A73E-4EAF-9BF2-7320CC0696B7Q36148614-FDFEA396-ACAF-412C-9FF9-D4EF1E925DD8Q36294611-261479A4-7461-4016-9041-363688F1E4D8Q36713632-1ED1DDFD-6A67-45E8-A12E-21B651647E1CQ36858404-A9091996-7B0B-4097-BC51-B6BBD3E94747Q37052852-4C079710-22D1-47F4-9F33-2BA3A7C8E5C7Q37058812-35D58FE7-31E0-4213-82CE-7438D8BC7F63Q37076348-6AD58E9A-EC0C-4833-81F6-D6193304580DQ37124784-BB4D62C3-4F38-4E4D-B644-2611AC55D562Q37167336-66530EE1-DCC8-46BF-BCED-5DFB322FA25AQ37234202-F2E4A818-18C5-49EB-886A-4212F6857227Q37313954-B9E7F309-D8B2-4747-A3D0-9CD759B00E14Q37383842-A38C214A-53F6-4965-84CA-982333759089Q37425224-D852C312-496B-4B71-A803-79847A464202Q37610100-50B29EBC-22C1-48FB-8457-FB0E9FB298E5Q37689852-7C98622E-CF53-45BE-BAB7-C40F36EA4157Q37702257-D577B5DB-00C4-432A-A26B-66CEDF140A32Q38084826-4C81E062-C24B-4B43-8B71-85C9F7621465Q38087423-7A8B7EBE-85F0-43C2-B91A-84D760F7E91BQ38167883-017C5FA6-F937-491F-9E55-5E34A0C041A6Q38255359-05498191-2A6E-4DD4-99E0-8E30F41F95AAQ38831634-8D9EA08C-FF71-4261-8548-37EDF549B568Q38878745-93ABAFEA-B182-4C74-B4BB-390035C97CD8Q38968910-D03A919A-0197-4630-8B2E-8D7B89D24C41Q39112952-203B3BF5-6211-4277-B3BB-DCD25954EFB8Q39169209-6ECE66FA-B300-4332-A465-EF171C98D250Q39361715-AFB64E68-F6A4-456C-B5AF-838F8806B3DEQ39504361-96ED66EC-35B4-4F9D-A39B-543AC54A37C5Q39654818-CE99E150-102E-4FDD-AF46-D634D3318B9AQ39750027-8B8BE2FE-2CC0-44D2-AE53-F35A546A1833Q39836322-34B8DBC6-3661-4E1F-B206-D0D9411E1B34Q39925586-55547631-EF05-4F06-8E16-58C580FE0BDCQ40117111-98B50857-40BD-4974-922F-1E8905200419Q40267357-49158251-38BB-44FC-A34C-92F358CA3CE9
P2860
Liposome-based approaches to overcome anticancer drug resistance.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Liposome-based approaches to overcome anticancer drug resistance.
@ast
Liposome-based approaches to overcome anticancer drug resistance.
@en
type
label
Liposome-based approaches to overcome anticancer drug resistance.
@ast
Liposome-based approaches to overcome anticancer drug resistance.
@en
prefLabel
Liposome-based approaches to overcome anticancer drug resistance.
@ast
Liposome-based approaches to overcome anticancer drug resistance.
@en
P2093
P1476
Liposome-based approaches to overcome anticancer drug resistance.
@en
P2093
Daryl C Drummond
John W Park
Keelung Hong
P304
P356
10.1016/S1368-7646(03)00082-7
P577
2003-10-01T00:00:00Z